학술논문
Eflapegrastim, a novel, long-acting GCSF for reducing chemotherapy-induced neutropenia: Integrated results from two phase III trials in breast cancer patients.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755